Stablecoin Development Corp is an on-chain holding company focused on long-duration participation in protocol-aligned digital asset ecosystems. The Company's initial digital asset focus is the Sky protocol ecosystem, with SKY as its core holding. Through staking and other on-chain activities, the Company seeks to generate protocol-level economic returns while maintaining rigorous governance and risk management oversight.
Last trade$0.7055
Day change$0.00 (0.00%)
Day range$0.682 – $0.733
Volume1,051,739
Market cap$52M
OpenXASE
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$51.91M
Price / earnings
0.09×
Price / book
0.28×
Price / sales
7.62×
EV / sales
6.57×
EV / EBITDA
25.92×
Profitability
Earnings per share
$7.68
Return on assets
298.43%
Return on equity
308.35%
Dividend yield
0%
Liquidity and leverage
Debt / equity
0×
Current ratio
17.2×
Quick ratio
17.2×
Cash ratio
15.72×
Cash flow
Price / cash flow
—
Price / free cash flow
—
Free cash flow
-$11.16M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for SDEV, quarterly periods
Line item
Q3 FY2026 Sep 30, 2026
Q2 FY2026 Jun 30, 2026
Revenue
$2.14M
$2.21M
Cost of revenue
$0
$0
Gross profit
$2.14M
$2.21M
Selling, general and administrative
$5.01M
$5.42M
Research and development
$0
$0
Total operating expenses
-$53.82M
$56.05M
Operating income
$55.96M
-$53.84M
Interest expense
$0
$0
Income before taxes
$55.96M
-$44.55M
Income taxes
$5.6M
-$3.48M
Net income
$50.36M
-$41.07M
Net income attributable to common shareholders
$50.36M
-$41.07M
EBITDA
$55.96M
-$53.84M
Basic earnings per share
$0.23
-$1.32
Diluted earnings per share
$0.23
-$1.32
Recent news
Company coverage with links to the original publishers.
Abbott Cooper PLLC is investigating potential fiduciary duty breaches by the board of directors of Stablecoin Development Corporation (formerly NovaBay Pharmaceuticals, Inc.). The investigation targets stockholders who continuously held shares since prior to August 19, 2025. Similar investigations are also underway for Kalaris Therapeutics (formerly AlloVir) and Abundia Global Impact Group (formerly Houston American Energy Corp.).
Abbott Cooper PLLC has announced investigations into potential fiduciary duty violations and wrongdoing by the boards of directors of three companies: Abundia Global Impact Group, Inc. (formerly Houston American Energy Corp.), Estrella Immunopharma, Inc., and Stablecoin Development Corporation (formerly NovaBay Pharmaceuticals, Inc.). The law firm is seeking stockholders who held shares continuously since July 1, 2025, or earlier to join the investigations on a contingency fee basis.
Abbott Cooper PLLC is investigating potential fiduciary duty violations by the Board of Stablecoin Development Corporation (formerly NovaBay Pharmaceuticals, Inc.) in connection with a private placement of preferred stock. The investigation targets stockholders who held shares prior to August 19, 2025.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.